Stability indicating RP-HPLC method development for docetaxel trihydrate
暂无分享,去创建一个
[1] M. Umekar,et al. Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell line. , 2019, International journal of biological macromolecules.
[2] Suprit D. Saoji,et al. Investigation of effectiveness of some extensively used polymers on thermoreversible properties of Pluronic® tri-block copolymers , 2018 .
[3] Nilesh R. Rarokar,et al. FORMULATION AND EVALUATION OF DOCETAXEL TRIHYDRATE LOADED SELF-ASSEMBLED NANOCARRIERS FOR TREATMENT OF HER2 POSITIVE BREAST CANCER , 2017 .
[4] Z. Qian,et al. Toxicity Evaluation and Anti-Tumor Study of Docetaxel Loaded mPEG-Polyester Micelles for Breast Cancer Therapy. , 2017, Journal of biomedical nanotechnology.
[5] Chul Soon Yong,et al. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells. , 2016, Colloids and surfaces. B, Biointerfaces.
[6] Vivek Dave,et al. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel , 2016, AAPS PharmSciTech.
[7] M. Galsky,et al. Docetaxel-based combination therapy for castration-resistant prostate cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] Jin Sun,et al. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. , 2008, Drug development and industrial pharmacy.
[9] J. Schellens,et al. Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093) , 2004, Cancer Chemotherapy and Pharmacology.
[10] G. Shabir,et al. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. , 2003, Journal of chromatography. A.
[11] M. Trudeau. Docetaxel: a review of its pharmacology and clinical activity. , 1996, The Canadian journal of oncology.
[12] M. Bissery. Preclinical pharmacology of docetaxel. , 1995, European journal of cancer.
[13] A. Greene,et al. Highly efficient, practical approach to natural taxol , 1988 .